StockData
Vyome Holdings, Inc logo

Vyome Holdings, Inc (HIND) stock

HINDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 1/30
$1.54+0.01 (+0.98%)

Close on Nov 17, 2026Market cap $10.84MP/E –Yield –

Vyome operating cash flow

Operating cash flow is the cash the business generates from its day-to-day operations.

Vyome's operating cash flow for the twelve months ending Jun 30, 2026 was -$5.58M, down 342.0% year over year. For fiscal 2025 it was -$3.75M. The highest annual figure on record is -$614.14K in fiscal 2024.

Annual operating cash flow

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$3.75M–
FY2024Dec 31, 2024-$614.14K–
FY2023Dec 31, 2023-$16.96M–
FY2022Dec 31, 2022-$21.90M–
FY2021Dec 31, 2021-$15.38M–
FY2020Dec 31, 2020-$8.55M–
FY2019Dec 31, 2019-$22.87M–
FY2018Dec 31, 2018-$29.43M–
FY2017Dec 31, 2017-$30.62M–
FY2016Dec 31, 2016-$19.37M–
FY2015Dec 31, 2015-$11.39M–
FY2014Dec 31, 2014-$9.91M–

Quarterly operating cash flow

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$903.71K–
Q1 FY2026Mar 31, 2026-$1.44M–
Q4 FY2025Dec 31, 2025-$1.48M–
Q3 FY2025Sep 30, 2025-$1.76M-162.5%
Q2 FY2025Jun 30, 2025-$306.25K–
Q1 FY2025Mar 31, 2025-$203.53K–
Q4 FY2024Dec 31, 2024-$2.97K–
Q3 FY2024Sep 30, 2024$2.82M–
Q2 FY2024Jun 30, 2024-$1.36M–
Q1 FY2024Mar 31, 2024-$2.07M–
Q4 FY2023Dec 31, 2023-$2.46M–
Q3 FY2023Sep 30, 2023-$2.78M–
Q2 FY2023Jun 30, 2023-$6.66M–
Q1 FY2023Mar 31, 2023-$5.06M–
Q4 FY2022Dec 31, 2022-$2.83M–
Q3 FY2022Sep 30, 2022-$5.27M–
Q2 FY2022Jun 30, 2022-$6.42M–
Q1 FY2022Mar 31, 2022-$7.38M–
Q4 FY2021Dec 31, 2021-$3.43M–
Q3 FY2021Sep 30, 2021-$7.80M–
Q2 FY2021Jun 30, 2021-$2.19M–
Q1 FY2021Mar 31, 2021-$1.96M–
Q4 FY2020Dec 31, 2020-$1.76M–
Q3 FY2020Sep 30, 2020-$976.00K–
Q2 FY2020Jun 30, 2020-$998.00K–
Q1 FY2020Mar 31, 2020-$4.81M–
Q4 FY2019Dec 31, 2019-$4.88M–
Q3 FY2019Sep 30, 2019-$3.99M–
Q2 FY2019Jun 30, 2019-$4.36M–
Q1 FY2019Mar 31, 2019-$9.64M–
Q4 FY2018Dec 31, 2018-$5.42M–
Q3 FY2018Sep 30, 2018-$5.29M–
Q2 FY2018Jun 30, 2018-$8.12M–
Q1 FY2018Mar 31, 2018-$10.60M–
Q4 FY2017Dec 31, 2017-$9.20M–
Q3 FY2017Sep 30, 2017-$7.02M–
Q2 FY2017Jun 30, 2017-$6.06M–
Q1 FY2017Mar 31, 2017-$8.35M–
Q4 FY2016Dec 31, 2016-$5.78M–
Q3 FY2016Sep 30, 2016-$4.93M–

More Vyome figures

See a number that looks wrong?